Back to results
Key Publications
June 8, 2017
Back to results
Statins, ezetimibe, and proprotein convertase subtilisin-kexin type 9 inhibitors to reduce low-density lipoprotein cholesterol and cardiovascular events.
Am J Cardiol. 2017;119:565-571
O'Keefe JH, DiNicolantonio JJ, Lavie CJ